Advanced search
Publication Cover
International Journal of General Medicine Volume 14, 2021 - Issue
Submit an article Journal homepage
93
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Clinicopathological Features and Prognostic Outcomes of Papillary Renal Cell Carcinoma

Xiaoyuan Qian1 Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaView further author information
,
Junlai Wan2 Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaView further author information
,
Can Qian3 Department of Traditional Chinese Medicine and Rheumatology, Southwest Hospital, Army Military Medical University, Chongqing, People’s Republic of ChinaView further author information
&
Jiaqiao Zhang1 Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 7523-7531 | Published online: 02 Nov 2021

References

  • Keegan KA, Schupp CW, Chamie K, et al. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol. 2012;188(2):391–397. doi:10.1016/j.juro.2012.04.006
  • Steffens S, Janssen M, Roos FC, et al. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma–a multicentre study. Eur J Cancer. 2012;48(15):2347–2352. doi:10.1016/j.ejca.2012.05.002
  • Pignot G, Elie C, Conquy S, et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology. 2007;69(2):230–235. doi:10.1016/j.urology.2006.09.052
  • Akhtar M, Al-Bozom IA, Al Hussain T. Papillary Renal Cell Carcinoma (PRCC): an update. Adv Anat Pathol. 2019;26(2):124–132. doi:10.1097/PAP.0000000000000220
  • Amin MB, Corless CL, Renshaw AA, et al. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol. 1997;21(6):621–635. doi:10.1097/00000478-199706000-00001
  • Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75(5):799–810. doi:10.1016/j.eururo.2019.02.011
  • Rosiello G, Palumbo C, Knipper S, et al. Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis. World J Urol. 2021;39(2):461–472. doi:10.1007/s00345-020-03187-y
  • Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10(6):537–544.
  • Delahunt B, Eble JN, McCredie MR, et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32(6):590–595. doi:10.1053/hupa.2001.24984
  • Bigot P, Bernhard JC, Gill IS, et al. The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery. World J Urol. 2016;34(3):347–352. doi:10.1007/s00345-015-1634-0
  • Ledezma RA, Negron E, Paner GP, et al. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. World J Urol. 2016;34(5):687–693. doi:10.1007/s00345-015-1692-3
  • Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93–105. doi:10.1016/j.eururo.2016.02.029
  • Ha YS, Chung JW, Choi SH, et al. Clinical significance of subclassification of papillary renal cell carcinoma: comparison of clinicopathologic parameters and oncologic outcomes between papillary histologic Subtypes 1 and 2 using the Korean renal cell carcinoma database. Clin Genitourin Cancer. 2017;15(2):e181–e186. doi:10.1016/j.clgc.2016.07.020
  • Yamashita S, Ioritani N, Oikawa K, et al. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis. Int J Urol. 2007;14(8):679–683. doi:10.1111/j.1442-2042.2007.01805.x
  • Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23(12):2763–2771. doi:10.1200/JCO.2005.07.055
  • Cornejo KM, Dong F, Zhou AG, et al. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome. Hum Pathol. 2015;46(10):1411–1417. doi:10.1016/j.humpath.2015.07.001
  • Ku JH, Moon KC, Kwak C, et al. Is there a role of the histologic subtypes of papillary renal cell carcinoma as a prognostic factor? Jpn J Clin Oncol. 2009;39(10):664–670. doi:10.1093/jjco/hyp075
  • Wong ECL, Di Lena R, Breau RH, et al. Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: type 1 vs. type 2. Urol Oncol. 2019;37(10):721–726. doi:10.1016/j.urolonc.2019.05.009
  • Selvi I, Demirci U, Bozdogan N, et al. The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results. Int Urol Nephrol. 2020;52(1):21–34. doi:10.1007/s11255-019-02285-0
  • Delahunt B, Eble JN, Egevad L, et al. Grading of renal cell carcinoma. Histopathology. 2019;74(1):4–17. doi:10.1111/his.13735
  • Selvi I, Demirci U, Bozdogan N, Basar H. Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma? Int Urol Nephrol. 2021;53(6):1135–1138. doi:10.1007/s11255-020-02766-7

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.